Helen Thackray
Direttore Tecnico/Scientifico/R&S presso BIOCRYST PHARMACEUTICALS, INC.
Patrimonio netto: 2 M $ in data 30/06/2024
Posizioni attive di Helen Thackray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 19/03/2021 | - |
| Direttore/Membro del Consiglio | 20/09/2019 | 19/03/2021 | |
| Independent Dir/Board Member | 20/09/2019 | 19/03/2021 | |
| Holy Cross Hospital (Maryland) | Corporate Officer/Principal | - | - |
| Gw School of Medicine & Health Sciences | Corporate Officer/Principal | 01/01/2000 | - |
Storia della carriera di Helen Thackray
Precedenti posizioni note di Helen Thackray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNOGEN, INC. | Direttore/Membro del Consiglio | 22/09/2021 | 12/02/2024 |
| Independent Dir/Board Member | 22/09/2021 | 12/02/2024 | |
| GLYCOMIMETICS, INC. | Direttore Tecnico/Scientifico/R&S | 06/01/2012 | 19/03/2021 |
| Corporate Officer/Principal | 01/01/2006 | 06/01/2012 | |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Corporate Officer/Principal | 01/01/2001 | 01/01/2006 |
| National Center for Health Statistics | Corporate Officer/Principal | - | - |
Formazione di Helen Thackray
| Stanford University | Undergraduate Degree |
| Gw School of Medicine & Health Sciences | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
Posizioni
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Government | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Biosynexus, Inc.
Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Health Technology |
| Holy Cross Hospital (Maryland) | |
| National Center for Health Statistics | Government |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Helen Thackray
- Esperienza
